EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study

Jason E Galloway, Andrea M Holderbaum, Namrata Arya, Suohui Zhang, Michael S Bodnar, Ruthann Norman, William E Carson, Lianbo Yu, Kari L Kendra, Christin E Burd

Aging and Cancer · 2020

DOI: 10.1002/aac2.12012 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Aging and Cancer, 2020. Verfasst von Jason E Galloway und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, The Ohio State University College of Arts and Sciences, Columbus, OH 43210. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of biologic aging on immune checkpoint inhibitor (ICI) toxicity and efficacy is underexplored in metastatic melanoma (MM). In peripheral blood T lymphocytes (PBTLs), biologic aging is characterized by changes in T‐cell composition and cellular senescence. Whether indicators of PBTL biologic aging vary in MM patients or can be used to predict premature ICI discontinuation (pID) is unknown.

Methods

We prospectively collected PBTLs from 117 cancer‐free controls and 46 MM patients scheduled to begin pembrolizumab or nivolumab monotherapy. Seventy‐four mRNAs indicative of T‐cell subset, activation, costimulation/inhibition, and cellular senescence were measured by Nanostring. Relationships between each mRNA and chronologic age were assessed in patients and controls. Candidate biomarkers were identified by calculating the hazard ratio (HR) for pID in patients divided into low and high groups based on log‐transformed mRNA levels or the magnitude by which each mRNA measurement deviated from the control trend (Δage). Area under the curve (AUC) analyses explored the ability of each biomarker to discriminate between patients with and without pID at 6 months and 1 year.

Results

Fifteen mRNAs correlated with chronologic age in controls, including markers of T‐cell subset, differentiation, cytokine production, and costimulation/inhibition. None of these mRNAs remained correlated with age in patients. Median follow‐up was 94.8 (1.6‐195.7) weeks and 35 of 46 patients discontinued therapy (23 progression, seven toxicity, and five comorbidity/patient preference). Elevated pretherapy CD8A (HR = 2.2 [1.1‐4.9]), CD45RB (HR = 2.9 [1.4‐5.8]), and TNFRSF14 (HR = 2.2 [1.1‐4.5]) levels predicted pID independent of Δage‐correction. CD3ε , CD27 , and FOXO1 predicted pID only after Δage‐correction (HR = 2.5 [1.3‐5.1]; 3.7 [1.8‐7.8]; 2.1 [1.1‐4.3]). AUC analysis identified Δage‐ CD3ε and Δage ‐CD27 as candidate predictors of pID (AUC = .73 and .75).

Conclusions

Correlations between transcriptional markers of PBTL composition and chronologic age are disrupted in MM. Correcting for normal, age‐related trends in biomarker expression unveils new biomarker candidates predictive of ICI outcomes.

Schlagwörter

Stichwörter der Autor:innen

Aging biomarkerCD27T cellaginganti-PD-1biomarkercheckpoint inhibitormelanomasenescence

Autor:innen und Institutionen

  • Department of Molecular Genetics, The Ohio State University College of Arts and Sciences, Columbus, OH 43210.
  • Department of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, OH 43210.
  • Department of Surgery, Division of Surgical Oncology, The Ohio State University College of Medicine, Columbus, OH 43210.
  • Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH 43210.
  • Medical Oncology Division, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH 43210.

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Galloway, J. E., Holderbaum, A. M., Arya, N., Zhang, S., Bodnar, M. S., Norman, R., Carson, W. E., Yu, L., Kendra, K. L., & Burd, C. E. (2020). Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study. Aging and Cancer. https://doi.org/10.1002/aac2.12012

Vancouver

Galloway JE, Holderbaum AM, Arya N, Zhang S, Bodnar MS, Norman R, et al. Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study. Aging and Cancer. 2020. doi:10.1002/aac2.12012

BibTeX
@article{Galloway2020,
  author = {Galloway, Jason E and Holderbaum, Andrea M and Arya, Namrata and Zhang, Suohui and Bodnar, Michael S and Norman, Ruthann and Carson, William E and Yu, Lianbo and Kendra, Kari L and Burd, Christin E},
  title = {Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study},
  journal = {Aging and Cancer},
  year = {2020},
  doi = {10.1002/aac2.12012}
}
Kostenlos starten →